# Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)

> **NCT00574782** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 2660 (actual)

## Conditions studied

- Hypercholesterolemia
- Coronary Heart Disease
- Peripheral Vascular Disease
- CVA
- Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00574782
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 2660 (ACTUAL)
- **Last updated:** 2007-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574782, "Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00574782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*